Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres

Tropical Medicine and International Health

Volumn 19, Issue 6, 2014, Pages 734-742

  Balcha, Taye T ^a,b   Winqvist, Niclas ^a,c   Sturegård, Erik ^d   Skogmar, Sten ^a   Reepalu, Anton ^a   Jemal, Zelalem H ^e   Tibesso, Gudeta ^f   Schön, Thomas ^g,h   Björkman, Per ^a  

^a LUND UNIVERSITY   (Sweden)

^b FEDERAL MINISTRY OF HEALTH   (Ethiopia)

^c Regional Department of Infectious Disease Control and Prevention   (Sweden)

^d Clinical Microbiology Regional and University Laboratories   (Sweden)

^e Oromia Regional Health Bureau   (Ethiopia)

^f Department of Medicine   (Ethiopia)

^g LINKÖPING UNIVERSITY   (Sweden)

^h KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

Antiretroviral therapy; Determine TB LAM; Ethiopia; Health centres; Lipoarabinomannan; TB

Indexed keywords

HEMOGLOBIN; LIPOARABINOMANNAN;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIPSTICK LATERAL URINE FLOW ASSAY; ETHIOPIA; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOASSAY; IMMUNOASSAY ANALYZER; LIPOARABINOMANNAN URINE LEVEL; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SCREENING TEST; SPUTUM ANALYSIS; SPUTUM SMEAR; SURVIVAL RATE; URINALYSIS; URINE LEVEL;

EID: 84899970375     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12308     Document Type: Article

References (31)

1. Balcha TT, Sturegård E, Winqvist N et al. (2014) Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture. PLoS ONE 9, e85478.
2. Chakravorty S & Tyagi JS (2005) Novel multipurpose methodology for detection of mycobacteria in pulmonary and extrapulmonary specimens by smear microscopy, culture, and PCR. Journal of Clinical Microbiology 43, 2697-2702.
3. Gustafson P, Gomes VF, Vieira CS et al. (2007) Clinical predictors for death in HIV-positive and HIV-negative tuberculosis patients in Guinea-Bissau. Infection 35, 69-80.
4. Hanekom W, Lawn SD, Dheda K & Whitelaw A (2010) Tuberculosis research update. Tropical Medicine and International Health 15, 981-989.
5. Hillemann D, Rüsch-Gerdes S, Boehme C & Richter E (2011) Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. Journal of Clinical Microbiology 49, 1202-1205.
6. Hunter SW, Gaylord H & Brennan PJ (1986) Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. Journal of Biological Chemistry 261, 12345-12351.
7. Kroidl I, Clowes P, Mwakyelu J et al. (2013) Reasons for false-positive lipoarabinomannan ELISA results in a Tanzanian population. Scandinavian Journal of Infectious Diseases 46, 144-148.
8. Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 1897-1908.
9. Lawn SD, Edwards DJ, Kranzer K et al. (2009) Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 23, 1875-1880.
10. Lawn SD, Kerkhoff AD, Vogt M & Wood R (2012a) High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay. Journal of Acquired Immune Deficiency Syndromes 60, 289-294.
11. Lawn SD, Kerkhoff AD, Vogt M & Wood R (2012b) Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. The Lancet Infectious Diseases 12, 201-209.
12. Lawn SD, Kerkhoff AD, Vogt M & Wood R (2013) HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays. BMC Medicine 11, 231.
13. Martinson NA, Karstaedt A, Venter WD et al. (2007) Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. AIDS 21, 2043-2050.
14. Minion J, Leung E, Talbot E et al. (2011) Lipoarabinomannan: systematic review. European Respiratory Journal 38, 1398-1405.
15. Ministry of Health of Ethiopia (2008) Guidelines for Management of Opportunistic Infections and Antiretroviral Treatment in Adolescents and Adults in Ethiopia. Ministry of Health of Ethiopia, Addis Ababa, Ethiopia.
16. Ministry of Health of Ethiopia (2012) Guidelines for Clinical and Programmatic Management of TB, Leprosy and TB/HIV in Ethiopia, 5th edn. Ministry of Health of Ethiopia, Addis Ababa, Ethiopia.
17. Peter J, Green C, Hoelscher M et al. (2010) Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Current Opinion in Pulmonary Medicine 16, 262-270.
18. Peter JG, Theron G, Zyl-Smit RV et al. (2012a) Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. European Respiratory Journal 40, 1211-1220.
19. Peter JG, Theron G, Muchinga TE, Govender U & Dheda K (2012b) The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS ONE 7, e39966.
20. Raviglione MC, Narain JP & Kochi A (1992) Analyses HIV-associated tuberculosis in developing countries : clinical features, diagnosis, and treatment. Bulletin of the World Health Organization 70, 515-526.
21. Reid MJ & Shah NS (2009) Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. The Lancet Infectious Diseases 9, 173-184.
22. Shah M, Variava E, Holmes CB et al. (2009) Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. Journal of Acquired Immune Deficiency Syndromes 52, 145-151.
23. Shah M, Martinson NA, Chaisson RE et al. (2010) Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. Journal of Clinical Microbiology 48, 2972-2974.
24. Talbot E, Munseri P, Teixeira P et al. (2012) Test characteristics of urinary lipoarabinomannan and predictors of Mortality among hospitalized HIV-infected tuberculosis suspects in Tanzania. PLoS ONE 7, e32876.
25. Tessema T, Hamasur B, Bjun G, Svenson S & Bjorvatn B (2001) Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Scandinavian Journal of Infectious Diseases 33, 279-284.
26. Theron G, Zijenah L, Chanda D et al. (2013) Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. The Lancet 6736, 1-12.
27. Wallis RS, Kim P, Cole S et al. (2013) Tuberculosis biomarkers discovery: developments, needs, and challenges. The Lancet Infectious Diseases 13, 362-372.
28. WHO (2012) Global Tuberculosis Report. WHO, Geneva, Switzerland.
29. WHO (2013) Revised Definitions and Reporting Framework for Tuberculosis. WHO, Geneva, Switzerland, pp. 1-40.
30. Wong EB, Omar T, Setlhako GJ et al. (2012) Causes of death on antiretroviral therapy: a post-mortem study from South Africa. PLoS ONE 7, e47542.
31. Wood R, Racow K, Bekker L et al. (2012) Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infectious Diseases 12, 47.